CR20140495A - 5-amino[1,4]thiazines como inhibidores de bace1 - Google Patents

5-amino[1,4]thiazines como inhibidores de bace1

Info

Publication number
CR20140495A
CR20140495A CR20140495A CR20140495A CR20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A CR 20140495 A CR20140495 A CR 20140495A
Authority
CR
Costa Rica
Prior art keywords
thiazines
bace1
inhibitors
amino
compound
Prior art date
Application number
CR20140495A
Other languages
English (en)
Inventor
Hans Hilpert
Thomas Woltering
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20140495A publication Critical patent/CR20140495A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención proporciona un compuesto de fórmula I
CR20140495A 2012-05-24 2014-10-27 5-amino[1,4]thiazines como inhibidores de bace1 CR20140495A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12169353 2012-05-24
PCT/EP2013/060352 WO2013174781A1 (en) 2012-05-24 2013-05-21 5-amino[1,4]thiazines as bace 1 inhibitors

Publications (1)

Publication Number Publication Date
CR20140495A true CR20140495A (es) 2014-12-01

Family

ID=48534350

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140495A CR20140495A (es) 2012-05-24 2014-10-27 5-amino[1,4]thiazines como inhibidores de bace1

Country Status (21)

Country Link
US (1) US9273042B2 (es)
EP (1) EP2855469B1 (es)
JP (1) JP6251249B2 (es)
KR (1) KR20150014934A (es)
CN (1) CN104334554B (es)
AU (1) AU2013265376B2 (es)
BR (1) BR112014028813A2 (es)
CA (1) CA2872179A1 (es)
CL (1) CL2014003123A1 (es)
CO (1) CO7131369A2 (es)
CR (1) CR20140495A (es)
EA (1) EA026004B1 (es)
IL (1) IL235681A (es)
MA (1) MA37691B1 (es)
MX (1) MX2014013839A (es)
NZ (1) NZ702254A (es)
PE (1) PE20150021A1 (es)
PH (1) PH12014502541B1 (es)
SG (1) SG11201407575PA (es)
UA (1) UA113438C2 (es)
WO (1) WO2013174781A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140054295A (ko) * 2011-08-22 2014-05-08 머크 샤프 앤드 돔 코포레이션 Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도
US9556135B2 (en) 2012-10-12 2017-01-31 Amgen, Inc. Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
WO2015017407A1 (en) 2013-07-30 2015-02-05 Amgen Inc. Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta- secretase
US9725468B2 (en) 2013-09-13 2017-08-08 Merck Sharp & Dohme Corp. C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
WO2016071211A1 (en) * 2014-11-03 2016-05-12 F. Hoffmann-La Roche Ag Bace1 inhibitors
AU2016236402B2 (en) 2015-03-20 2019-08-01 F. Hoffmann-La Roche Ag BACE1 inhibitors
JP6895424B2 (ja) * 2015-08-12 2021-06-30 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Bace1阻害剤
US11629154B2 (en) 2018-04-27 2023-04-18 Shionogi & Co., Ltd. Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity
CN110467611B (zh) * 2018-05-11 2022-09-27 广东东阳光药业有限公司 亚氨基噻二嗪二氧化物衍生物及其用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090221579A1 (en) * 2004-10-15 2009-09-03 Jeffrey Scott Albert Substituted Amino-Compounds and Uses Thereof
US8461160B2 (en) * 2009-05-08 2013-06-11 Hoffmann-La Roche, Inc. Dihydropyrimidinones
US8188079B2 (en) * 2009-08-19 2012-05-29 Hoffman-La Roche Inc. 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines
US20110065695A1 (en) * 2009-09-11 2011-03-17 Jeremy Beauchamp Use of aminodihydrothiazines for the treatment or prevention of diabetes
UA103272C2 (uk) * 2009-12-11 2013-09-25 Ф. Хоффманн-Ля Рош Аг 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2
MX2013011947A (es) 2011-04-13 2014-01-16 Merck Sharp & Dohme Iminotiazinas 5-sustituidas y sus monoxidos y dioxidos como inhibidores de la enzima que encinde la proteina precursora amiloide en el sitio beta, composiciones y su uso.
KR20140054295A (ko) * 2011-08-22 2014-05-08 머크 샤프 앤드 돔 코포레이션 Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도

Also Published As

Publication number Publication date
CO7131369A2 (es) 2014-12-01
IL235681A (en) 2017-10-31
JP2015517548A (ja) 2015-06-22
US20150141413A1 (en) 2015-05-21
EP2855469A1 (en) 2015-04-08
UA113438C2 (xx) 2017-01-25
CA2872179A1 (en) 2013-11-28
PH12014502541A1 (en) 2015-01-21
EA026004B1 (ru) 2017-02-28
US9273042B2 (en) 2016-03-01
KR20150014934A (ko) 2015-02-09
MA37691B1 (fr) 2016-11-30
IL235681A0 (en) 2015-02-01
BR112014028813A2 (pt) 2017-06-27
MA37691A1 (fr) 2016-03-31
CN104334554B (zh) 2017-10-31
HK1201261A1 (en) 2015-08-28
MX2014013839A (es) 2015-02-04
AU2013265376B2 (en) 2017-07-20
SG11201407575PA (en) 2014-12-30
AU2013265376A1 (en) 2014-11-13
PE20150021A1 (es) 2015-01-28
EP2855469B1 (en) 2019-06-19
PH12014502541B1 (en) 2015-01-21
JP6251249B2 (ja) 2017-12-20
CL2014003123A1 (es) 2015-02-27
NZ702254A (en) 2016-08-26
EA201492097A1 (ru) 2015-04-30
CN104334554A (zh) 2015-02-04
WO2013174781A1 (en) 2013-11-28

Similar Documents

Publication Publication Date Title
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
CR20140306A (es) Fluormetil -5,6-dihidro-4h-[1,3] oxazinas
UY34156A (es) Compuestos inhibidores de metaloenzimas
IN2015DN00598A (es)
UY34523A (es) Derivados de betulina
UY34445A (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
PH12015500263A1 (en) New bicyclic derivatives
CR20140535A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
UY34092A (es) Nuevos compuestos como inhibidores de jak
EA201590321A1 (ru) Дейтерированный барицитиниб
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
UY34145A (es) Compuestos inhibidores de metaloenzimas
UA110338C2 (xx) Хімічні сполуки
UY34146A (es) Compuestos inhibidores de metaloenzimas
CR20130539A (es) Triazolopiridinas
UY34472A (es) Derivados modificados de 4-fenil-piridina
UY34602A (es) ?Derivados de bencimidazolil- e imidazopiridinil-metilamina?
IN2014DN09346A (es)
MX341456B (es) Amino-quinolinas como inhibidores de cinasa.
MX2014014531A (es) Derivados de aminoquinazolina y piridopirimidina.
EA201591634A1 (ru) Дигидропиридопиримидиновые соединения
CR20130419A (es) Derivados heterocíclicos de amina
CR20150271A (es) Peptidos como agonistas de oxitocina
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
DOP2015000059A (es) Amino-quinolinas como inhibidores de cinasa